Mixed Tumor, Mullerian  >>  iniparib (BSI 201)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iniparib (BSI 201) / Sanofi
NCT00687687: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma

Completed
2
22
US
paclitaxel, carboplatin, BSI-201 (Iniparib), SAR204550
Sanofi, Gynecologic Oncology Group
Uterine Carcinosarcoma
03/10
12/11

Download Options